Sponsors

ITOC11 thankfully acknowledges the support of the following companies and institutions

We’re innovating with next-generation therapies, combinations and technologies to expand our oncology portfolio and aim to bring more life to people with cancer. Over the past few years, Gilead and Kite have received eight indication approvals across more than 50 countries, expanding our oncology platform across major pathways, including cell therapies and medicines for difficult-to-treat metastatic cancers. We’re purposefully building our oncology portfolio and pipeline to address the greatest gaps in care. Read more: https://www.gileadsciences.de/

MedChemExpress (MCE) is a top global supplier of research chemicals and bioactive compounds, serving research institutes, labs, biotech firms, and pharma companies. Our catalog features over 60,000 inhibitors and agonists, 36,000 oligonucleotides, and 20,000 life science products like proteins, peptides, antibodies, and fluorescent kits. We also offer one-stop screening libraries for drug discovery. Our experienced team provides friendly and efficient service to meet your unique needs.

Miltenyi Biotec is a global leader innovating technologies and services for patient-specific cell and gene therapies, transforming scientific discoveries into practical treatments for personalized medicine. With over 35 years of expertise, it supports biomedical discoveries and translates them into clinical applications, enhancing patient access to new therapies. Miltenyi Biotec focuses on offering integrated solutions for complex challenges in treating cancers, autoimmune diseases, and inherited disorders. Its Miltenyi Bioindustry division provides expert guidance to therapy developers efficiently from process development to commercialization. Headquartered in Bergisch Gladbach, it employs 4,900 people across 24 countries.

OMICS EMPOWER PTE. LTD.

We provide multi-omics technical services for life science research, including comprehensive products such as single-cell sequencing, spatial omics, yeast libraries, and bioinformatics analysis. We are committed to enhancing life through technology and benefiting humanity through scientific innovation.

Wilhelm Sander Stiftung

The Wilhelm Sander Foundation is one of the most important independent scientific supporters of medical research, particularly in the field of innovative cancer research in Germany and Switzerland. Since its inception, the Foundation has provided hundreds of millions of dollars in funding for research in Germany and Switzerland. This makes the Wilhelm Sander Foundation one of the most important private research foundations in Germany. The foundation was established from the estate of the businessman of the same name, who died in 1973. Click to read more.

Wolfgang Wilmanns Stiftung

The purpose of the Wolfgang Wilmanns Foundation is the support of leukaemia and tumour research at the universities in Munich with the involvement of the TZM. This purpose is particularly fulfilled through awarding prizes to young researchers or research groups at the universities in Munich for outstanding performance in this area. The foundation is a non-profit organisation. Click to read more.

We herewith confirm that all sponsorship income is free of any attempt to influence the programme, individual sessions, subjects for discussions, content or choice of faculty members